Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
2019 · Cancer Cell · 469 citations
https://doi.org/10.1016/j.ccell.2019.10.001
J
J. Brandon Parker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
2.7K
Citations
27
h-index
32
i10-index
J. Brandon Parker is an academic researcher from Northwestern University. The author has contributed to research in topics: Uterine Myomas and Treatments & Genomics and Chromatin Dynamics & RNA Research and Splicing. The author has an h-index of 27, co-authored 44 publications.
ORCID: 0000-0002-9152-8913Papers by this author
worksHost Cell Factor-1 Recruitment to E2F-Bound and Cell-Cycle-Control Genes Is Mediated by THAP11 and ZNF143
2014 · Cell Reports · 75 citations
https://doi.org/10.1016/j.celrep.2014.09.051
Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer
2019 · npj Precision Oncology · 29 citations
https://doi.org/10.1038/s41698-019-0103-4
Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution
2021 · Cell Reports · 22 citations
https://doi.org/10.1016/j.celrep.2021.108927
Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype
2024 · F&S Science · 3 citations
https://doi.org/10.1016/j.xfss.2024.07.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat